日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Role of Menstrual Bleeding Assessments in Sickle Cell Clinics

月经出血评估在镰状细胞病诊所中的作用

Rush, Gillian; Mohamed, Rania E; Moffatt-Bazile, Kimberly; Jamalapur, Sri Lakshmi; Valenti, Gianna G; Sathi, Bindu K; Jacob, Seethal; Van Doren, Layla N; Velez, Maria C; Ogu, Ugochi; Smink, Gayle M; Schultz, Corinna L; DiVirgilio, Nicole; Gomez, Esteban; Quarmyne, Maa-Ohui; Light, Jennifer; Gupta, Kalpna; Zhang, Li; Vichinsky, Elliott P; Hagar, Ward; Rivers, Angela; Treadwell, Marsha; Strouse, John J; Bhasin, Neha

Decision-making about gene therapy in transfusion dependent thalassemia

输血依赖型地中海贫血基因治疗的决策

Quarmyne, Maa-Ohui; Ross, Diana; Sinha, Cynthia; Bakshi, Nitya; Boudreaux, Jeanne; Krishnamurti, Lakshmanan

T Cell-Epstein-Barr Virus-Associated Hemophagocytic Lymphohistiocytosis (HLH) Occurs in Non-Asians and Is Associated with a T Cell Activation State that Is Comparable to Primary HLH

T细胞-Epstein-Barr病毒相关性噬血细胞性淋巴组织细胞增生症(HLH)可见于非亚洲人群,且与原发性HLH类似的T细胞活化状态相关。

Shamriz, Oded; Kumar, Deepak; Shim, Jenny; Briones, Michael; Quarmyne, Maa-Ohui; Chonat, Satheesh; Lucas, Laura; Edington, Holly; White, Michael H; Mahajan, Advay; Park, Sunita; Chandrakasan, Shanmuganathan

Correction to: T Cell‑Epstein‑Barr Virus-Associated Hemophagocytic Lymphohistiocytosis (HLH) Occurs in Non‑Asians and Is Associated with a T Cell Activation State that Is Comparable to Primary HLH

更正:T细胞-Epstein-Barr病毒相关性噬血细胞性淋巴组织细胞增生症(HLH)可发生于非亚洲人群,且与类似于原发性HLH的T细胞活化状态相关

Shamriz, Oded; Kumar, Deepak; Shim, Jenny; Briones, Michael; Quarmyne, Maa-Ohui; Chonat, Satheesh; Lucas, Laura; Edington, Holly; White, Michael H; Mahajan, Advay; Park, Sunita; Chandrakasan, Shanmuganathan

Assessment of Patient and Caregiver Attitudes and Approaches to Decision-Making Regarding Bone Marrow Transplant for Sickle Cell Disease: A Qualitative Study

镰状细胞病患者及其照护者对骨髓移植决策的态度和方法的评估:一项定性研究

Bakshi, Nitya; Katoch, Deeksha; Sinha, Cynthia B; Ross, Diana; Quarmyne, Maa-Ohui; Loewenstein, George; Krishnamurti, Lakshmanan

Eculizumab for complement mediated thrombotic microangiopathy in sickle cell disease

依库珠单抗用于治疗镰状细胞病中的补体介导的血栓性微血管病

Chonat, Satheesh; Graciaa, Sara; Shin, H Stella; Newton, Joanna G; Quarmyne, Maa-Ohui; Boudreaux, Jeanne; Tang, Amy; Zerra, Patricia E; Rollins, Margo R; Josephson, Cassandra D; Brown, Clark; Joiner, Clinton H; Fasano, Ross M; Stowell, Sean R

Patient and family experience with chronic transfusion therapy for sickle cell disease: A qualitative study

镰状细胞病患者及其家属接受慢性输血治疗的经历:一项定性研究

Hawkins, Lauren M; Sinha, Cynthia B; Ross, Diana; Yee, Marianne E M; Quarmyne, Maa-Ohui; Krishnamurti, Lakshmanan; Bakshi, Nitya

Improving an Administrative Case Definition for Longitudinal Surveillance of Sickle Cell Disease

改进镰状细胞病纵向监测的行政病例定义

Snyder, Angela B; Zhou, Mei; Theodore, Rodney; Quarmyne, Maa-Ohui; Eckman, James; Lane, Peter A

Contribution of alternative complement pathway to delayed hemolytic transfusion reaction in sickle cell disease

替代补体途径对镰状细胞病迟发性溶血性输血反应的贡献

Chonat, Satheesh; Quarmyne, Maa-Ohui; Bennett, Caroline M; Dean, Christina L; Joiner, Clinton H; Fasano, Ross M; Stowell, Sean R

Hydroxyurea effectiveness in children and adolescents with sickle cell anemia: A large retrospective, population-based cohort

羟基脲治疗镰状细胞贫血症儿童和青少年的疗效:一项大型回顾性、基于人群的队列研究

Quarmyne, Maa-Ohui; Dong, Wei; Theodore, Rodney; Anand, Sonia; Barry, Vaughn; Adisa, Olufolake; Buchanan, Iris D; Bost, James; Brown, Robert C; Joiner, Clinton H; Lane, Peter A